Recuperación de autores

Gorka Barrenetxea *
Referencias bibliográficas
1. Karaki RZ, Samarraie SS, Younis NA, Lahloub TM, Ibrahim MH. Blastocyst culture and transfer: a step toward improved in vitro fertilization outcome. Fertil Steril, 2002; 77:114-8. 2. Cruz JR, Dubey AK, Patel J, Peak D, Hartog B, Gindoff PR. Is blastocyst transfer useful as an alternative treatment for patients with multiple in vitro fertilization failures? Fertil Steril, 1999; 72:218-20. 3. Shapiro BS, Richter KS, Harris DC, Daneshmand ST. A comparison of day 5 and day 6 blastocyst transfers. Fertil Steril, 2001; 75:1126-30. 4. Shapiro BS, Richter KS, Harris DC, Daneshmand ST. Implantation and pregnancy rates are higuer for oocyte donor cycles after blastocyst-stage embryo transfer. Fertil Steril, 2002; 77:1296-7. 5. Gardner DK, Lane M. Culture and selection of viable blastocyst: a feasible for human IVF? Hum Reprod Update, 1997; 3:367-82. 6. Wilson M, Hartke K, Kiehl M, Rodgers J, Brabec C, Lyles R. Integration of blastocyst transfer for all patients. Fertil Steril, 2002; 77:693-696. 7. Gardner DK, Schoolcraft WB, Wagley L, Schlenker T, Stevens J, Jesla JA. A prospective randomized trial of blastocyst culture and transfer in in.vitro fertilization. Hum Reprod, 1998; 13:3434-40. 8. Jones GM, Trounson AO, Gardner DK, Kausche A, Lolatgis N, Wood C. Evoulution of a culture protocol for successful blastocyst development and pregnancy. Hum Reprod, 1998; 13:169-77. 9. Edwards RG, Beard HK. Blastocyst stage transfer: pitfalls and benefits (is the success of human IVF more a mattter of genetics and evolution of growing blastocysts?) Human Reprod, 1999: 14:1-4. 10. Huisman GJ, Fauser BC, Eijkemans MJ, Pieters MH. Implantation rates after in vitro fertilization and transfer of a maximum of two embryos that have undergone three to five days of culture. Fertil Steril, 2000; 73:117-22. 11. Kovacic B, Vlaisavljevic V, Reljic M, Lovrec VG. Clinical outcome of day 2 versus day 5 transfer in cycles with one or two developed embryos. Fertil Steril, 2002; 77: 529-36. 12. Schoolcraft WB, Gardner DK. Blastocyst culture and transfer increases the efficiency of oocyte donation. Fertil Steril, 2000; 74:482-6. 13. Gardner DK, Lane M. Culture of viable human blastocysts in defined sequential serum-free media. Hum Reprod, 1998; 13 Suppl. 3: 148-59. 14. Levron J, Shulman A, Bider D, Seidman D, Levin T, Dor J. A prospective randomized study comparing day 3 with blastocyst-stage embryo transfer. Fertil Steril, 2002; 77:1300-1. 15. Milki AA, Hinckley MD, Fisch JD, Dasig D, Behr B. Comparison of blastocyst trasnfer with day 3 embryo transfer in similar patient populations. Fertil Steril, 2000; 73: 126-9. 16. Behr B, Gebhardt J, Lyon J, Milki AA. Factors relating cryopreserved blastocyst transfer program. Fertil Steril, 2002; 77:697-9.

Otros artículos de Gorka Barrenetxea Barrenetxea G, Centeno MM, Barbazán MJ, Montoya F, Neyro JL, Rodríguez Escudero FJ. Estudio de la influencia del tratamiento inductor de la ovulación en los resultados de la inseminación terapéutica con semen de donante. Clin Invest Gin Obs, 1992; 19(9):370-375. Barrenetxea G, Echanojáuregui AD, Schneider J, Centeno MM, De La Rica M, Rodríguez Escudero FJ. Factores etiológicos implicados en los abortos de repetición. Clin Inves Gin Obs 1993; 20:282-9. Barrenetxea G, Echanojáuregui AD, Pérez C, Rodríguez Escudero FJ, Arranz C, Arrieta A, Masdevall MD. Implicación de la histocompatibilidad y la alosensibilización en los abortos de repetición. Med Clin (Barc), 1995; 104:721-7. Barrenetxea G, Schneider J, Centeno MM, Martínez AJ, Fernández de Larrinoa A, González del Tánago J, Rodríguez Escudero FJ. Pure theca cell tumors. A clinicopathologic study of 29 cases. Eur J Gynecol Oncol 1990; 11(6):429-431. Barrenetxea G, Martín Mateos M, Barbazán MJ, Montoya F, Matía JC, Rodríguez Escudero FJ. Serum CA 125, CA 15.3 and CA 19.9 levels and surgical findings in patients undergoing second look operations for ovarian carcinomas. Eur J Gynecol Oncol 1990; XI(5):369-374. Barrenetxea G, Montoya F, Barbazán MJ, Rementería AM, Rodríguez Escudero FJ. Cervical conization results and complications. A twelve-year experience. The Cervix 1992; 10:39-43. Barrenetxea G, Corcóstegui B, Rodríguez Escudero FJ, Arranz C, García Masdevall D. HLA sharing and recurrent spontaneous abortion in humans. Human Reproduction, 1992; Suppl. 1 S65 (Abstract). Barrenetxea G, Mendoza R, Aparicio MV, Rodríguez Escudero FJ, Arranz C, García Masdevall G. Immunotherapy in recurrent spontaneous abortion. Human Reproduction, 1992; Suppl 1 S177 (Abstract). Barrenetxea G, Schneider J, Tánago JG, Pérez C, Centeno MM, Rodríguez Escudero FJ. Angiosarcoma of the breast and pregnancy: a new therapeutic approach. Eur J Obst Gynecol Reprod Biol, 1995; 60:87-89. Barrenetxea G, Schneider J, Centeno MM, Romero H, De la Rica M, Rodríguez Escudero FJ. Chemotherapy induced emesis. Management of early and delayed emesis in milder emetogenic regimens Cancer Chemoth Pharm, 1996; 38(5):471-5. Barrenetxea G, Schneider J, Rodríguez Escudero FJ. Abdominal mass in a young woman. Pitfals and delayed diagnosis. A case report. Eur J Gynaecol Oncol, 1996; 17:507-9. Barrenetxea G, Schneider J, Rodríguez Escudero FJ. Abdominal mass in a young woman. Pitfals and delayed diagnosis. A case report. Eur J Gynaecol Oncol, 1996; 17:507-9. Barrenetxea G, Schneider J, Llorente MF. Use of serum tumor markers for the diagnosis and follow-up of breast cancer. Oncology, 1998; 55:447-9. Barrenetxea G. Vulvovaginitis candidiásica. Rev IberoAm Mic, 2002; 19(1):22-4. Barrenetxea G, López de Larruzea A, Ganzábal T, Jiménez R, Carbonero K, Mandiola M, Atutxa F, Guembe A, Iñarra MJ. Blastocyst transfer: a step toward improved IVF outcome. Human Reprod, 2003; 18(Suppl. 1):122-3.

Para comunicarse con Gorka Barrenetxea mencionar a SIIC como referencia: C. Pérez Galdós 19-4, 48010, Bilbao, España gorkabz@euskalnet.net